Cow's Milk Protein Allergy Management

Diagnostic Approach and General Considerations

• The European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) recommends that breastfeeding should be continued with maternal elimination of cow's milk and dairy products from the diet, as cow's milk proteins transfer through breast milk in sufficient quantities to cause allergic reactions 1, 2, 3
• The American Academy of Pediatrics suggests that improvement typically occurs within 72-96 hours to 1-2 weeks of strict maternal dietary elimination 1, 2
• Consultation with a registered dietitian is essential to ensure nutritional adequacy of the maternal diet, with particular attention to calcium supplementation, as recommended by the Academy of Nutrition and Dietetics 2, 3

Management for Breastfed Infants

• The European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) recommends that the mother must completely eliminate all sources of cow's milk protein including milk, cheese, yogurt, butter, and hidden sources in processed foods 2
• If symptoms persist despite strict maternal elimination for 2 weeks, consultation with an allergy specialist is warranted, according to the American Academy of Allergy, Asthma, and Immunology 2
• A rechallenge after 1-2 weeks of elimination should be performed to confirm the diagnosis before implementing longer periods of dietary restriction, as suggested by the European Academy of Allergy and Clinical Immunology 3

Management for Formula-Fed Infants

• The European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) recommends that an extensively hydrolyzed formula (eHF) of cow's milk protein is the first-line treatment, with demonstrated efficacy of 80-90% 1, 2
• An amino acid-based formula (AAF) should be used if symptoms are life-threatening, severe, or do not resolve after 2-4 weeks of eHF treatment, according to the American Academy of Pediatrics 1, 2
• Soy formula is NOT recommended as a first-line alternative due to cross-reactivity affecting 20-40% of infants with CMPA; it may only be considered for infants >6 months after establishing tolerance by clinical challenge, as recommended by the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) 1, 2
• Goat's milk and sheep's milk are unsuitable alternatives due to high protein homology with cow's milk, according to the Food and Agriculture Organization of the United Nations 2, 3

Special Considerations for Intestinal Failure

• The European Society for Clinical Nutrition and Metabolism recommends that in newborns and infants with intestinal failure or short bowel syndrome, breast milk is the enteral feed of first choice 4
• If breast milk is unavailable, start with elemental (amino acid-based) formula in early infancy and severe illness, switching to extensively hydrolyzed and then polymeric feeds as tolerated, as suggested by the American Society for Parenteral and Enteral Nutrition 4
• There is evidence that breast milk is associated with shorter duration of parenteral nutrition in intestinal failure, according to the European Society for Clinical Nutrition and Metabolism 4
• Amino acid-based formulae have shown greater efficiency in decreasing parenteral nutrition requirements compared to extensively hydrolyzed feeds in case series, as reported by the Journal of Pediatric Gastroenterology and Nutrition 4

Critical Pitfalls to Avoid

• Do not implement unnecessarily restrictive maternal diets beyond elimination of confirmed allergens, as this may compromise maternal nutrition and breastfeeding ability, according to the Academy of Nutrition and Dietetics 1, 2, 3
• Do not discontinue breastfeeding prematurely when maternal elimination diet can effectively manage symptoms, as recommended by the World Health Organization 2
• Do not use regular soy formula as first-line treatment due to significant cross-reactivity risk, according to the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) 1, 2
• Do not delay switching to amino acid formula if the infant has failure to thrive or severe symptoms that persist despite eHF, as suggested by the American Academy of Pediatrics 1, 2

Management of Cow's Milk Protein Allergy

Treatment Options

• Partially hydrolyzed formulas are inadequate for treatment of confirmed Cow's Milk Protein Allergy, as stated by the American Academy of Allergy, Asthma, and Immunology, with a strength of evidence based on recent studies 5, 6

Formula Characteristics

Management of Milk Allergy in Infants

Nutritional Considerations

• Children with milk allergy are more likely to consume inadequate calcium and vitamin D compared to children without milk allergy, according to the American Academy of Allergy, Asthma, and Immunology 7, 8, 9
• The possibility of consuming less-than-recommended intake of calcium and vitamin D is reduced if the child receives nutrition counseling or consumes appropriate commercial formula, as recommended by the American Academy of Pediatrics 7, 8, 9

Nutritional Monitoring Requirements

• All children with food allergy require nutritional counseling and regular growth monitoring, as stated by the American Academy of Allergy, Asthma, and Immunology 7, 8, 9, 10
• Children with 2 or more food allergies are at higher risk for growth impairment compared to those with 1 food allergy, according to the American Academy of Pediatrics 7, 8, 9
• Height-for-age percentiles may be lower in children with milk allergy compared to healthy children, as reported by the American Academy of Allergy, Asthma, and Immunology 7, 8, 9
• Regular monitoring helps identify inadequate nutritional intake early, particularly for calcium, vitamin D, and protein, as recommended by the American Academy of Pediatrics 7, 8, 9

Extensively Hydrolyzed Casein Formula Reduces Allergy Diagnoses in Infants with Cow’s Milk Protein Allergy

Evidence from the GINI Study

• In infants with confirmed cow’s milk protein allergy, feeding an extensively hydrolyzed casein formula (eHF‑C) lowered the rate of subsequent allergy diagnoses compared with a standard cow’s milk formula, as shown in the GINI randomized controlled trial (Journal of Allergy and Clinical Immunology, 2010) – Level 1 evidence (RCT) 11

Key Clinical Features and Risk Factors for Cow’s Milk Protein Allergy in Infants

IgE‑Mediated Immediate Reactions

• Infants may develop acute symptoms such as urticaria, angioedema, wheezing, cough, or vomiting within minutes to up to 2 hours after ingesting cow’s milk protein, indicating an IgE‑mediated response. 12
• Anaphylaxis, although rare, can occur as a life‑threatening manifestation of IgE‑mediated cow’s milk protein allergy. 12

Non‑IgE‑Mediated Delayed Reactions

• Symptoms may appear hours to several days after exposure to cow’s milk protein, reflecting a delayed immunologic mechanism. 12
• Food protein‑induced enterocolitis syndrome (FPIES) can present with profuse vomiting and lethargy in affected infants. 12

Mixed IgE and Non‑IgE‑Mediated Presentations

• Eosinophilic esophagitis may occur, characterized by feeding difficulties and failure to thrive, representing a mixed immunologic pattern. 12

Risk Factors

• A family history of atopic disease (e.g., eczema, asthma, allergic rhinitis) increases the infant’s risk of developing cow’s milk protein allergy. 12

Allergy Evaluation and Dairy Introduction in Children with Eczema

Prevalence of IgE‑mediated Food Allergy in Eczema

• Up to 37 % of children younger than 5 years with moderate‑to‑severe eczema have IgE‑mediated food allergy, indicating a high risk that warrants careful assessment before dietary changes. 13

Indications for Allergy Testing in Young Children with Atopic Dermatitis

• Children < 5 years with moderate‑to‑severe atopic dermatitis should be tested for cow’s milk, egg, peanut, wheat, and soy allergy when (a) the dermatitis persists despite optimized skin‑care and topical therapy, or (b) there is a reliable history of an immediate reaction after ingesting a specific food. (Evidence from pediatric cohort studies) 13, 14

Interpretation of Allergy Test Results

• False‑positive results are common; a positive skin‑prick test or specific IgE alone does not confirm clinical allergy. Clinical correlation is required before imposing dietary restrictions. (Observational data) 13
• Children must be demonstrated to be clinically allergic (symptomatic reaction confirmed by oral food challenge) rather than merely sensitized before restricting foods. (Combined evidence from two pediatric studies) 13, 14

Evidence on Partially Hydrolyzed Formula for Allergy Prevention

• The European Academy of Allergy and Clinical Immunology (EAACI) 2021 guidelines state that there is no strong evidence that partially or extensively hydrolyzed formulas prevent atopic disease, even in infants at high risk for allergy. (Guideline recommendation, low‑to‑moderate certainty) 15

Clinical Decision Pathway for Dairy Introduction

• If formal allergy testing has not been performed and eczema remains moderate‑to‑severe despite optimal topical management, allergy testing is warranted before introducing regular dairy. (Guideline‑based recommendation) 13, 14
• When testing is negative or the child is only sensitized (no clinical reaction), regular dairy products can be safely introduced according to age‑appropriate feeding guidelines. (Clinical practice based on negative testing) 13, 14
• If a cow’s milk protein allergy is confirmed by a double‑blind, placebo‑controlled food challenge, dairy must be avoided until tolerance develops; management then follows standard CMA protocols (e.g., extensively hydrolyzed or amino‑acid‑based formula). (Standard of care) 13, 14

Guidelines for Management of Cow’s Milk Protein Allergy in Infants

Prevention Recommendations

• The European Academy of Allergy and Clinical Immunology (EAACI) 2021 guideline advises against the use of partially hydrolyzed formulas for primary prevention of allergic disease, even in infants at high risk for allergy. 16

Treatment Algorithms

First‑line Therapy

• For infants with confirmed cow’s milk protein allergy, initiate a casein‑based extensively hydrolyzed formula (eHF) as the primary therapeutic option. [17][18]
• Assess clinical response to the eHF after 2–4 weeks of therapy to determine adequacy of symptom control and growth. [19][20]

Second‑line Therapy

• If gastrointestinal symptoms persist after 2–4 weeks of eHF, switch to an amino‑acid‑based formula (AAF). Approximately 10–20 % of infants with food‑protein‑induced enterocolitis syndrome (FPIES) will require this more elemental formula. [17][18]

Management of FPIES

• Infants with FPIES typically return to baseline health within 3–10 days after transitioning to a hypoallergenic formula. [17][18]21

Soy Formula Contraindication

• Soy‑based formulas should not be used as first‑line nutrition in infants younger than 6 months, because cross‑reactivity with cow’s milk protein occurs in 20–40 % of cases. [17][18]

Maternal Dietary Elimination (Breast‑fed Infants)

• Small amounts of cow’s milk protein consumed by the mother can be secreted into breast milk at levels sufficient to provoke allergic reactions in the infant. [22][19]20
• If infant gastrointestinal symptoms persist despite strict maternal elimination of dairy for 2–4 weeks, the next step is to introduce an extensively hydrolyzed formula. [19][20]